1. Metabolism and Endocrine Disorders: What Wnt Wrong?
   Carolina N. Franco et al, 2022, Frontiers in Endocrinology CrossRef
2. Genetic and Epigenetic Causes of Pituitary Adenomas
   Mengqi Chang et al, 2021, Frontiers in Endocrinology CrossRef
3. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance
   Hatim Boughanem et al, 2024, Journal of Translational Medicine CrossRef
4. β-Catenin is reduced in membranes of human prolactinoma cells and it is inhibited by temozolomide in prolactin secreting tumor models
   Gianina Demarchi et al, 2022, Tumor Biology CrossRef
5. Conserved aging-related signatures of senescence and inflammation in different tissues and species
   Emanuel Barth et al, 2019, Aging CrossRef
6. Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression
   Gianina Demarchi et al, 2022, Frontiers in Endocrinology CrossRef
7. Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis
   Karlijn van Loon et al, 2021, Cancer and Metastasis Reviews CrossRef
8. Research progress on the role of the Wnt signaling pathway in pituitary adenoma
   Wencai Wang et al, 2023, Frontiers in Endocrinology CrossRef